Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17 BEDFORD, Mass., Feb. 20 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, announced plans
View HTML
Toggle Summary Insulet Corporation to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 7, 2008
Insulet Corporation to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 7, 2008 BEDFORD, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in wearable insulin pump technology with its OmniPod ® Insulin
View HTML
Toggle Summary Insulet Corporation and DexCom Announce Development Agreement
Insulet's OmniPod(R) Personal Diabetes Manager to Integrate DexCom Continuous Glucose Monitoring Technology
View HTML
Toggle Summary Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008 BEDFORD, Mass., Jan 02, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that
View HTML
Toggle Summary Insulet Reports Third Quarter 2007 Results
OmniPod Customer Base Grows over 30% in Third Quarter Production Increases to 45,000 OmniPods per Month
View HTML
Toggle Summary Insulet Corporation Announces Pricing of Secondary Public Offering
Insulet Corporation Announces Pricing of Secondary Public Offering BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced the pricing of its public offering of 4,898,398 shares
View HTML
Toggle Summary Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, announced plans to release its financial
View HTML
Toggle Summary Insulet Corporation Announces Proposed Secondary Public Offering of Common Stock
Insulet Corporation Announces Proposed Secondary Public Offering of Common Stock BEDFORD, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, announced today that it has filed a registration statement
View HTML
Toggle Summary Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program BEDFORD, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the maker of the OmniPod ® Insulin Management System, today announced that it has been awarded a home medical
View HTML
Toggle Summary Insulet Corporation to Present at the William Blair Small Cap Growth Conference on October 3, 2007
Insulet Corporation to Present at the William Blair Small Cap Growth Conference on October 3, 2007 BEDFORD, Mass., Sept. 26 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that Duane DeSisto,
View HTML
Toggle Summary Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
BEDFORD, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that Duane DeSisto, Chief Executive Officer, will participate in the Thomas Weisel Partners Healthcare Conference. Mr.
View HTML
Toggle Summary Insulet Reports Second Quarter 2007 Results
OmniPod Customers Nearly Double in First Half of 2007
View HTML
Toggle Summary Insulet Corporation to Report Second Quarter 2007 Financial Results on Tuesday, August 14th
Insulet Corporation to Report Second Quarter 2007 Financial Results on Tuesday, August 14th BEDFORD, Mass., July 26, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer of the OmniPod Insulin Management System, announced plans to release its
View HTML
Toggle Summary Insulet Reports First Quarter 2007 Results
Insulet Reports First Quarter 2007 Results BEDFORD, Mass., June 21 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod Insulin Management System, today announced financial results for its first quarter ended March 31, 2007.
View HTML
Toggle Summary OmniPod Insulin Management System Lets Type 1 Diabetic Endurance Bicycling Champions Focus on the Race
OCEANSIDE, Calif. - June 12, 2007 - When a cycling team of eleven Type 1 diabetics step onto their bikes for their second 3,043-mile Race Across America again this week, they'll be able to concentrate on another win - not insulin injections and blood glucose monitoring.
View HTML